Literature DB >> 9175156

Tachykinins in the gut. Part II. Roles in neural excitation, secretion and inflammation.

P Holzer1, U Holzer-Petsche.   

Abstract

The preprotachykinin-A gene-derived peptides substance (substance P; SP) and neurokinin (NK) A are expressed in intrinsic enteric neurons, which supply all layers of the gut, and extrinsic primary afferent nerve fibers, which innervate primarily the arterial vascular system. The actions of tachykinins on the digestive effector systems are mediated by three different types of tachykinin receptor, termed NK1, NK2 and NK3 receptors. Within the enteric nervous system, SP and NKA are likely to mediate, or comediate, slow synaptic transmission and to modulate neuronal excitability via stimulation of NK3 and NK1 receptors. In the intestinal mucosa, tachykinins cause net secretion of fluid and electrolytes, and it appears as if SP and NKA play a messenger role in intramural secretory reflex pathways. Secretory processes in the salivary glands and pancreas are likewise influenced by tachykinins. The gastrointestinal arterial system may be dilated or constricted by tachykinins, whereas constriction and an increase in the vascular permeability are the only effects seen in the venous system. Various gastrointestinal disorders are associated with distinct changes in the tachykinin system, and there is increasing evidence that tachykinins participate in the hypersecretory, vascular and immunological disturbances associated with infection and inflammatory bowel disease. In a therapeutic perspective, it would seem conceivable that tachykinin antagonists could be exploited as antidiarrheal, antiinflammatory and antinociceptive drugs.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9175156     DOI: 10.1016/s0163-7258(96)00196-9

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  44 in total

1.  Different effects of steroidal therapy on neuropeptide-active enzymes in male and female human saliva.

Authors:  Federica Albo; Riccardo Antonangeli; Antonella Cavazza; Mario Marini; L Giorgio Roda; Paolo Rossi
Journal:  Neurochem Res       Date:  2002-09       Impact factor: 3.996

2.  Inhibitory effect of Iboga-type indole alkaloids on capsaicin-induced contraction in isolated mouse rectum.

Authors:  Mee Wah Lo; Kenjiro Matsumoto; Masumi Iwai; Kimihito Tashima; Mariko Kitajima; Syunji Horie; Hiromitsu Takayama
Journal:  J Nat Med       Date:  2010-11-02       Impact factor: 2.343

3.  Differential role of tachykinin NK3 receptors on cholinergic excitatory neurotransmission in the mouse stomach and small intestine.

Authors:  J G De Man; B Y De Winter; H U De Schepper; A G Herman; P A Pelckmans
Journal:  Br J Pharmacol       Date:  2008-09-22       Impact factor: 8.739

4.  Characterization of the [125I]-neurokinin A binding site in the circular muscle of human colon.

Authors:  F J Warner; A Comis; R C Miller; E Burcher
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

Review 5.  Autonomous innervation in renal inflammatory disease-innocent bystander or active modulator?

Authors:  Tilmann Ditting; Gisa Tiegs; Roland Veelken
Journal:  J Mol Med (Berl)       Date:  2009-07-12       Impact factor: 4.599

Review 6.  Enteric co-innervation of motor endplates in the esophagus: state of the art ten years after.

Authors:  Jürgen Wörl; Winfried L Neuhuber
Journal:  Histochem Cell Biol       Date:  2005-02-24       Impact factor: 4.304

7.  Effect of Gingerol on Cisplatin-Induced Pica Analogous to Emesis Via Modulating Expressions of Dopamine 2 Receptor, Dopamine Transporter and Tyrosine Hydroxylase in the Vomiting Model of Rats.

Authors:  Weibin Qian; Xinrui Cai; Yingying Wang; Xinying Zhang; Hongmin Zhao; Qiuhai Qian; Zhihong Yang; Zhantao Liu; Junichi Hasegawa
Journal:  Yonago Acta Med       Date:  2016-06-29       Impact factor: 1.641

8.  Tachykinins potently stimulate human small bowel blood flow: a laser Doppler flowmetry study in humans.

Authors:  P T Schmidt; M Lördal; B Gazelius; P M Hellström
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

9.  The endogenous cannabinoid system protects against colonic inflammation.

Authors:  Federico Massa; Giovanni Marsicano; Heike Hermann; Astrid Cannich; Krisztina Monory; Benjamin F Cravatt; Gian-Luca Ferri; Andrei Sibaev; Martin Storr; Beat Lutz
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

10.  Hydrogen Sulfide and its Interaction with Other Players in Inflammation.

Authors:  Sumeet Manandhar; Priyanka Sinha; Grace Ejiwale; Madhav Bhatia
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.